BioCentury
ARTICLE | Clinical News

AC-1204: Completed Phase III enrollment

May 23, 2016 7:00 AM UTC

Accera completed enrollment of >400 patients with mild to moderate AD in the double-blind, placebo-controlled, U.S. Phase III NOURISH AD trial evaluating once-daily oral AC-1204 for 26 weeks. NOURISH ...